Daniel J. Lippis - 01 Jan 2024 Form 3 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, JAPAC
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
01 Jan 2024
Net transactions value
$0
Form type
3
Filing time
08 Jan 2024, 17:01:31 UTC
Next filing
20 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EW Common Stock 17,758 01 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EW Employee Stock Option (Right to Acquire) 01 Jan 2024 Common Stock 3,429 $36.75 Direct
holding EW Employee Stock Option (Right to Acquire) 01 Jan 2024 Common Stock 5,565 $45.28 Direct
holding EW Employee Stock Option (Right to Acquire) 01 Jan 2024 Common Stock 7,134 $59.26 Direct
holding EW Employee Stock Option (Right to Acquire) 01 Jan 2024 Common Stock 6,810 $72.68 Direct
holding EW Employee Stock Option (Right to Acquire) 01 Jan 2024 Common Stock 6,320 $88.78 Direct
holding EW Employee Stock Option (Right to Acquire) 01 Jan 2024 Common Stock 5,440 $93.31 Direct
holding EW Employee Stock Option (Right to Acquire) 01 Jan 2024 Common Stock 4,870 $105.93 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24, Power of Attorney, attached.